Clinical Trial Update: Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial investigating mechanism of acquired immune escape in metastatic cancer progressing on checkpoint inhibitor therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 4 | Status: COMPLETED